Literature DB >> 9672968

Nonneoplastic liver disease: evaluation with CT and MR imaging.

S Kawamoto1, P A Soyer, E K Fishman, D A Bluemke.   

Abstract

A wide range of nontumorous hepatic diseases may have an impact on liver function and serve as indications for computed tomographic (CT) or magnetic resonance (MR) imaging. New imaging techniques such as spiral CT and fast MR imaging aid in detecting and characterizing these disease processes and in assessing the extent of disease. Infectious liver disease (eg, hepatic abscess, echinococcal disease, fungal infection) typically has low attenuation at CT and high signal intensity at T2-weighted MR imaging. Cholangitis is characterized by ductal dilatation at both CT and MR imaging. In acute portal vein thrombosis, the thrombus has low attenuation at CT and is hyperintense relative to liver at MR imaging. Hepatic infarcts usually appear as well-circumscribed, peripheral, wedge-shaped areas of decreased attenuation at CT. The causes or complications of cirrhosis can be most readily identified with MR imaging. In patients with chronic radiation-induced hepatitis, CT shows the irradiated parenchyma as a region of increased attenuation, whereas T1- and T2-weighted MR imaging demonstrate geographic areas of low and high signal intensity, respectively. Hemachromatosis has homogeneously increased liver attenuation at CT and decreased signal intensity at gradient-echo MR imaging in particular. Familiarity with the CT and MR imaging features of the spectrum of nonneoplastic conditions of the liver is essential in making an accurate diagnosis.

Entities:  

Mesh:

Year:  1998        PMID: 9672968     DOI: 10.1148/radiographics.18.4.9672968

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  9 in total

Review 1.  CT and MR imaging evaluation of living liver donors.

Authors:  Federica Vernuccio; Susan A Whitney; Kadiyala Ravindra; Daniele Marin
Journal:  Abdom Radiol (NY)       Date:  2021-01

Review 2.  [Diffuse and vascular hepatic diseases].

Authors:  S Kreimeyer; L Grenacher
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

3.  Potential risk factors for nonalcoholic steatohepatitis related to pancreatic secretions following pancreaticoduodenectomy.

Authors:  Sun Choon Song; Seong Ho Choi; Dong Wook Choi; Jin Seok Heo; Woo Seok Kim; Min Jung Kim
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

4.  Pylephlebitis With Hepatic Abscess Complicating a Case of Acute Pancreatitis in a Young Male: Startling Complication of Intra-Abdominal Sepsis.

Authors:  Dhruv Talwar; Sourya Acharya; Samarth Shukla; Sunil Kumar; Akhilesh Annadatha
Journal:  Cureus       Date:  2022-01-16

5.  Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis.

Authors:  Sang Jung Park; Jin Dong Kim; Yeon Seok Seo; Beom Jin Park; Min Ju Kim; Soon Ho Um; Chang Ha Kim; Hyung Joon Yim; Soon Koo Baik; Jin Yong Jung; Bora Keum; Yoon Tae Jeen; Hong Sik Lee; Hoon Jai Chun; Chang Duck Kim; Ho Sang Ryu
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

6.  Radiation-induced liver disease as a mimic of liver metastases at serial PET/CT during neoadjuvant chemoradiation of distal esophageal cancer.

Authors:  Michael J Grant; Ryne A Didier; Jeffrey S Stevens; Dmitry D Beyder; John G Hunter; Charles R Thomas; Fergus V Coakley
Journal:  Abdom Imaging       Date:  2014-10

7.  Spontaneous resolution of portal vein thrombosis.

Authors:  Vishnu Banumukala; Adarsh Babu
Journal:  Case Rep Gastroenterol       Date:  2008-11-07

8.  Pylephlebitis with Liver Abscess Secondary to Chronic Appendicitis: A Radiological Conundrum.

Authors:  Divya Santosh; Gavin Low
Journal:  J Clin Imaging Sci       Date:  2016-09-20

9.  Risk factors for development of nonalcoholic fatty liver disease after pancreatoduodenectomy.

Authors:  Yoshiro Fujii; Atsushi Nanashima; Masahide Hiyoshi; Naoya Imamura; Koichi Yano; Takeomi Hamada
Journal:  Ann Gastroenterol Surg       Date:  2017-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.